Novartis AG (NVS)
NYSE: NVS
· Real-Time Price · USD
124.07
1.98 (1.62%)
At close: Aug 15, 2025, 3:02 PM
Novartis Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 13.64B | 12.86B | 11.94B | 11.76B | 10.09B | 9.16B | 8.76B | 7.59B | 7.65B | 7.03B | 6.96B | 21.8B | 22.98B | 24.18B | 24.02B | 9.81B | 8.98B | 7.96B |
Depreciation & Amortization | 6B | 5.91B | 6.07B | 6.03B | 7.17B | 7.84B | 8.52B | 8.88B | 7.79B | 7.77B | 7.18B | 6.75B | 6.18B | 5.82B | 6.11B | 6.21B | 6.49B | 6.75B |
Stock-Based Compensation | 1.06B | 1.05B | 1.04B | 1.02B | 970M | 935M | 865M | 814M | 828M | 810M | 823M | 821M | 775M | 756M | 736M | 700M | 729M | 743M |
Other Working Capital | 160M | -25M | -292M | -490M | 507M | 408M | 1.16B | 1.85B | 1.26B | 654M | -1.24B | -9M | -520M | -296M | 241M | 287M | -158M | 362M |
Other Non-Cash Items | -1.38B | 1.96B | 7.04B | 6.75B | 6.23B | 1.64B | -3.51B | -2.59B | -1.84B | -993M | -1.14B | -16.73B | -17.15B | -18.05B | -18.16B | -3.75B | -4.57B | -4.31B |
Deferred Income Tax | 1.97B | 2.06B | 1.7B | 975M | 814M | 671M | 676M | 1.21B | 1.52B | 1.41B | 1.42B | 1.79B | 1.91B | 2.18B | 2.12B | 1.93B | 1.94B | 1.75B |
Change in Working Capital | -497M | -989M | -1.55B | -1.94B | -1.59B | -1.7B | -872M | 97M | -604M | -496M | -1B | -412M | -480M | -296M | 241M | 287M | -158M | 362M |
Operating Cash Flow | 20.79B | 19B | 17.62B | 15.97B | 15.06B | 13.77B | 14.46B | 16.02B | 15.37B | 15.54B | 14.24B | 14.01B | 14.21B | 14.59B | 15.07B | 15.19B | 13.42B | 13.25B |
Capital Expenditures | -3.98B | -4.15B | -3.81B | -3.47B | -3.35B | -3.62B | -2.93B | -2.8B | -2.69B | -2.28B | -2.67B | -3B | -2.96B | -2.97B | -2.97B | -3.02B | -3.1B | -2.96B |
Cash Acquisitions | -1.99B | -3.59B | -3.87B | -3.62B | -7.02B | -3.82B | -3.58B | -3.58B | -131M | -106M | -903M | 19.44B | 19.41B | 19.47B | 20.1B | -177M | -272M | -272M |
Purchase of Investments | -3.43B | -3.65B | -3.65B | -1.92B | -944M | -693M | -750M | -10.76B | -17.43B | -30.67B | -34.82B | -39.87B | -33.97B | -20.78B | -16.61B | -1.14B | -1.87B | -1.89B |
Sales Maturities Of Investments | 3.98B | 5B | 3.71B | 3.3B | 2.12B | 1.1B | 11.6B | 21.08B | 33.25B | 35.35B | 39.49B | 30.52B | 18.08B | 16.18B | 2.76B | 2.38B | 2.51B | 2.45B |
Other Investing Acitivies | -2.42B | -2.18B | -1.36B | -1.45B | 683M | 673M | 1.27B | 1.95B | 301M | 431M | 368M | 413M | 501M | 898M | 931M | 1.03B | 995M | 410M |
Investing Cash Flow | -5.32B | -6.28B | -7.51B | -6.24B | -8.08B | -5.92B | 5.6B | 5.89B | 13.3B | 2.72B | 1.47B | 7.5B | 1.07B | 12.79B | 4.21B | -926M | -1.74B | -2.26B |
Debt Repayment | 2.06B | 2.71B | 4.39B | 5.11B | 310M | -1.23B | -1.45B | -3.26B | -2.93B | -2.22B | -2.75B | -4.66B | -2.78B | -5.16B | -4.8B | -2.63B | 264M | 390M |
Common Stock Repurchased | -11.05B | -9.95B | -8.33B | -6.82B | -5.59B | -6.93B | -8.72B | -10.15B | -11.24B | -11B | -10.65B | -8.12B | -5.69B | -3.68B | -3.06B | -4.68B | -5.32B | -4.62B |
Dividend Paid | -7.82B | -7.75B | -7.62B | -7.62B | -7.62B | -5.21B | -7.25B | -7.25B | -7.25B | -7.25B | -7.51B | -7.51B | -7.51B | -7.51B | -7.37B | -7.37B | -7.37B | -7.37B |
Other Financial Acitivies | -337M | -142M | -177M | -15M | 3.1B | 3.13B | 3.15B | 3B | -151M | 232M | 342M | 465M | -637M | -914M | -1.03B | -1.27B | -94M | -160M |
Financial Cash Flow | -17.14B | -15.13B | -11.74B | -9.35B | -9.8B | -10.24B | -14.28B | -17.66B | -21.57B | -20.24B | -20.56B | -19.82B | -16.61B | -17.25B | -16.26B | -15.95B | -12.52B | -11.76B |
Net Cash Flow | -1.25B | -2.4B | -1.93B | 1.2B | -2.98B | -2.53B | 5.88B | 3.68B | 7.26B | -1.85B | -4.89B | 1.51B | -1.49B | 10.05B | 2.75B | -1.78B | -800M | -727M |
Free Cash Flow | 16.81B | 14.85B | 13.8B | 12.51B | 11.71B | 10.15B | 11.53B | 13.23B | 12.67B | 13.26B | 11.56B | 11.01B | 11.26B | 11.62B | 12.1B | 12.18B | 10.32B | 10.29B |